Mary Clare Jalonick

Associated Press
Latest in Regulation
Practical AI Lessons and Strategies
Sponsored
Practical AI Lessons and Strategies
August 5, 2026
Us Binary Flag Mirsad Sarajlic
You Know Continuous Compliance — You Just Haven't Done It for Cybersecurity Yet
July 30, 2026
A wind turbine base is visible at Sunrise Wind offshore wind farm that is under construction off the coast of Montauk Point, New York, April 23, 2026.
Trump Cites National Security to Stop Offshore Wind Development
July 17, 2026
Us Binary Flag Mirsad Sarajlic
CMMC's Third-Party Audit Just Disappeared. Your Liability Didn't.
July 15, 2026
Related Stories
Apple 56b3a8173265a
Product Development
Apple to Pay $600M+ in Patent Case
Muslim Prayer 56b3965451118
Operations
Workers Terminated over Prayer Dispute
Continental 56b387eb4dbdc
Supply Chain
Five Million More Air Bag Recalls
Practical AI Lessons and Strategies
Sponsor Content
Practical AI Lessons and Strategies
More from Mary Clare Jalonick
Modeling AI ROI Like a CFO, Not a Vendor
Sponsored
Modeling AI ROI Like a CFO, Not a Vendor
A six-step framework for building AI business cases that survive audit scrutiny, board review, and hindsight.
August 6, 2026
Facebook CEO Mark Zuckerberg testifies before a House Energy and Commerce hearing on Capitol Hill in Washington, Wednesday, April 11, 2018, about the use of Facebook data to target American voters in the 2016 election and data privacy.
Regulation
Facebook Regulation Not 'Inevitable'
But increased regulation 'is a very real possibility.'
April 12, 2018
Facebook CEO Mark Zuckerberg arrives to testify before a joint hearing of the Commerce and Judiciary Committees on Capitol Hill in Washington, Tuesday, April 10, 2018, about the use of Facebook data to target American voters in the 2016 election.
Regulation
Zuckerberg Addresses Privacy Concerns
The Facebook CEO faced aggressive questioning from lawmakers who accused him of failing to protect the personal information of millions of Americans.
April 11, 2018
Facebook CEO Mark Zuckerberg arrives on Capitol Hill in Washington, Monday, April 9, 2018, to meet with Sen. Dianne Feinstein, D-Calif., the ranking member of the Senate Judiciary Committee.
Safety
Zuckerberg Faces Congressional Inquisition
The Facebook CEO is undergoing a two-day congressional inquisition that will be pivotal for the company's future.
April 10, 2018
In this May 16, 2012, file photo, the Facebook logo is displayed on an iPad in Philadelphia. Facebook says a Russian internet agency posted more than 80,000 pieces of content during and after the 2016 election, and that content was distributed to an estimated 126 million users. The company plans to disclose the new numbers to Congress in testimony to the Senate Judiciary Committee on Tuesday, Oct. 31, 2017, according to a source familiar with the testimony.
Product Development
Tech Companies Find Russian Activity
The issue goes far beyond ads.
October 31, 2017
In this Sept. 25, 2017, file photo, Sen. Ron Wyden, D-Ore., speaks on Capitol Hill in Washington. Wyden wants to know how well prepared the country’s top voting machine manufacturers are against hackers. In letters shared with The Associated Press, Wyden asks the CEOs of six election technology firms to answer a range of questions detailing how they protect sensitive voter data and test their own internal security systems.
Product Development
Officials Seek Info From Voting Machine Makers
A senator asks the companies to detail their internal security protocols, including whether they test their systems against penetration attempts by outside experts.
October 3, 2017
Regulation
USDA Announces New Animal Welfare Regs
The rule is a victory for animal rights groups two days before President Barack Obama leaves office.
January 19, 2017
In this Sept. 10, 2015 file photo, Sen. Bernie Sanders, I-Vt., left, and Rep. Elijah Cummings, D-Md., leave a news conference on Capitol Hill in Washington. Sanders and Cummings on Thursday, Oct. 20, 2016, demanded information from a drug company that has raised prices on a leukemia drug, calling increases of tens of thousands of dollars a sign the company puts profits before patients.
Supply Chain
Lawmakers Decry Leukemia Drug Price
They also said they are investigating whether the company tried to boost profits by tweaking pill dosages and quantities to charge insurers and patients more for less medicine.
October 20, 2016
House Speaker Paul Ryan of Wis., right, hides his face and laughs at Sen. Charles Schumer, D-N.Y., bends his nail during a ceremony to drive in the first nails to signifying the start of construction on the 2017 presidential inaugural platform, Wednesday, Sept. 21, 2016, on Capitol Hill in Washington.
Operations
Construction Begins on Inauguration Platform
Building the 10,000 square-foot platform from scratch is a major job. Trees have to be uprooted, a fountain has to be temporarily filled in and even some marble has to be removed.
September 21, 2016
Mylan CEO Heather Bresch is defending the cost for life-saving EpiPens and is offering no suggestion that there are plans to lower prices.
Regulation
Mylan CEO Set to Defend EpiPen Prices
"Price and access exist in a balance, and we believe we have struck that balance," Heather Bresch says in prepared testimony released by the House Oversight and Government Reform Committee.
September 21, 2016
Bayer CropScience North America President and CEO Jim Blome testifies on Capitol Hill in Washington, Tuesday, Sept. 20, 2016, before the Judiciary Committee hearing on a proposed $66 billion merger of American seed and weed-killer company Monsanto and German medicine and farm chemical maker Bayer.
Regulation
Monsanto, Bayer Defend $66B Merger
Officials say deal would lead to greater investments in technology that could help American farmers.
September 20, 2016
Monsanto Logo 57e142ad709d4
Regulation
Senate Scrutinizes Bayer-Monsanto Merger
The deal would create a global agricultural and chemical giant with a broad array of products.
September 20, 2016
In this July 8, 2016 file photo, a package of EpiPens, an epinephrine autoinjector for the treatment of allergic reactions is displayed in Sacramento, Calif. Lawmakers are demanding more information on why the price for live-saving EpiPens has skyrocketed. EpiPens are used largely by children to ward off potentially fatal allergic reactions, and its price has surged in recent years. A two-dose package cost less than $60 nine years ago. The cost is now closer to $400.
Supply Chain
EpiPen Price Has Skyrocketed
A two-dose package cost less than $60 nine years ago. The cost is now closer to $400.
August 23, 2016
Genetically Modified Ap 576c36949df15
Regulation
Senators Reach Deal on GMO Labeling
The deal announced Thursday by the Senate Agriculture Committee would require labeling of genetically modified organisms, or GMOs, in packaged foods nationwide.
June 23, 2016
Sodium Fda I Stock 574ee0e695f10
Regulation
FDA Asks Food Industry for Less Salty Foods
The idea is to persuade companies and restaurants — many of which have already lowered sodium levels in their products — to take a more consistent approach.
June 1, 2016